PLT-012

N/A

Report date: 2026/04/07 20:00:20
First In Class

Base Information

Drug NamePLT-012
Drug Alias NamePLT-012EI-012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionPlatelet glycoprotein 4 inhibitors
TargetsPlatelet glycoprotein 4
Therapy Area/IndicationsSolid tumoursInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesElixiron Immunotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPilatus Biosciences Inc
Inactive CompaniesPilatus Biosciences SA
Active IndicationsSolid tumours
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A